DrugRepV Browse Page


DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for Plant extract are 21




DrugRepV_ID Antiviral Name
Drug type
Primary Indication
Secondary Indication
Strain
Pathways
Assay
Activity
Clinical Status
References
DrugRepV_0014Anthocyanidin
Plant extract
NA
Zika virus
GZ01, a recent Asian lineage
NA
Plaque assay
No significant effect (20 %)
NA
29033372
DrugRepV_1634Veratridine
Plant extract
NA
Influenza virus
A/Anhui/01/2013
Pathway
Transcriptomic response-DEG
Decrease
NA
24991006
DrugRepV_1704Baicalein
Plant extract
Influenza
Zika virus
MR766
NA
Cell viability assay
No significant effect (0 %)
Phase II
27571349
DrugRepV_1775Baicalein
Plant extract
Influenza
Zika virus
MR766
NA
Cell viability assay
No significant effect (0 %)
Phase II
27571349
DrugRepV_1846Baicalein
Plant extract
Influenza
Zika virus
MR766
NA
Cell viability assay
No significant effect
Phase II
27571349
DrugRepV_2565Ginkgolide A
Plant extract
Inflammatory disorder | immunological disorder
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
Increase (-1.1811648 %)
Nutraceutical
27742486
DrugRepV_2699Genipin
Plant extract
NA
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
Increase (-2.9384281 %)
NA
27742486
DrugRepV_2978Chrysin
Plant extract
NA
Chikungunya virus
CHIKV replicon
NA
EGFP assay
Decrease (50 %)
Experimental
22205980
DrugRepV_2987Chrysin
Plant extract
NA
Chikungunya virus
CHIKV replicon
NA
Rluc assay
Decrease (50 %)
Experimental
22205980
DrugRepV_3021Bisdemethoxycurcumin
Plant extract
NA
Zika virus
HD78788
NA
Plaque assay
Decrease
Early Phase I
28343845
DrugRepV_3025Bisdemethoxycurcumin
Plant extract
NA
Chikungunya virus
La Reunion strain, 06-049 AM258994
NA
Plaque assay
Decrease
Early Phase I
28343845
DrugRepV_3029Bisdemethoxycurcumin
Plant extract
NA
Zika virus
HD78788
NA
Plaque assay
Decrease (50 %)
Early Phase I
28343845
DrugRepV_3034Bisdemethoxycurcumin
Plant extract
NA
Chikungunya virus
La Reunion strain, 06-049 AM258994
NA
Plaque assay
Decrease (50 %)
Early Phase I
28343845
DrugRepV_3123Chelidonine
Plant extract
NA
Chikungunya virus
CHIKV-0708
NA
Immunoflourescence assay
Decrease (93.22 %)
NA
23275491
DrugRepV_3159Iota-carrageenan
Plant extract
Common Cold
Chikungunya virus
Ross C347
NA
Cytopathic effect (CPE) assay
Decrease (50 %)
Investigational
14670584
DrugRepV_4298Baicalein
Plant extract
Influenza
Chikungunya virus
NA
NA
NA
Decrease (50 %)
Phase II
27460167
DrugRepV_6167Baicalin
Plant extract
Influenza
Dengue virus
NA
Pathway
Focus forming reduction assay
Decrease
Phase II
24965553
DrugRepV_6220Baicalein
Plant extract
Influenza
Dengue virus
New Guinea C
Pathway
Focus forming reduction assay
Decrease (50 %)
Phase II
23140177
DrugRepV_7344Baicalein
Plant extract
Influenza
Japanese encephalitis virus
HE861351
Pathway
Focus forming reduction assay
Decrease (50 %)
Phase II
23222683
DrugRepV_7346Baicalein
Plant extract
Influenza
Japanese encephalitis virus
HE861351
Pathway
Real-time PCR
Decrease (68.46 ± 1.19 %)
Phase II
23222683
DrugRepV_7987Baicalein
Plant extract
Influenza
Enterovirus
41
Pathway
Plaque assay
Decrease (50 %)
Phase II
32293397